In recent years, more and more celebrities — like Elon Musk and Whoopi Goldberg — have spoken up about using GLP-1 ...

Jefferies investment banker Chris Roop discussed the Big Pharma M&A outlook with Business Insider. Check out the types of ...

In 2024, several celebrities made headlines with their remarkable weight loss journeys, inspiring millions by prioritizing ...

Our beauty icons range from legendary models like Iman and Alek Wek ... Cosmetic procedures such as nose jobs and the increasing popularity of weight-loss drugs like Ozempic and Wegovy reflect a ...

A study in pigs has shown that the active ingredient in Ozempic and Wegovy directly boosts heart health, in addition to the ...

An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...

Eli Lilly's Zepbound drug holds potential to dominate the global obesity market due to its superior efficacy and strategic ...

GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...

Lilly’s offering is expected to surpass Novo’s Wegovy in the space, and, according to a report this week from GlobalData, it could happen much sooner than later. The analysts pointed to ...

Wegovy is considered a safe and effective treatment for long-term weight loss. Possible problems with long-term use to discuss with your doctor include pancreatitis, gallbladder disease, and ...

While West Virginia's employee health insurance program covers drugs like Ozempic for people with type 2 diabetes, officials ...